Without a step change in the productivity of pharmaceutical research and development, it will be difficult to tackle the public health challenges facing societies worldwide. Public–private partnerships could play a key role in achieving this step change, but they need to be well designed and led.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Acknowledgements
M.S. and E.Z. would like to thank J. Bouthier, B. Stowasser and the Sanofi IMI team for their contributions to this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.S. and E.Z. are employees and shareholders of Sanofi.
Rights and permissions
About this article
Cite this article
Said, M., Zerhouni, E. The role of public–private partnerships in addressing the biomedical innovation challenge. Nat Rev Drug Discov 13, 789–790 (2014). https://doi.org/10.1038/nrd4438
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4438
